Formulation:
Each uncoated tablet contains:
- Clindamycin Hydrochloride USP equivalent to Clindamycin 150/300 mg
Indication:
- For the treatment of infected wounds and abscesses, and infected mouth cavity and dental infection, caused by or associated with Staphylococcus spp, Streptococcus spp (except Streptococcus faecalis), Bacteroides spp, Fusobacterium necrophorum, and Clostridium perfringens. To help provide antimicrobial cover during dental procedures.
- For the treatment of superficial pyoderma associated with Staphylococcus intermedius.
Dosage and administration:
Canine Infected Wounds, Abscesses and Dental Infections
-
- Oral: 2.5 mg/Ib body weight every 12 hours.
- Duration: Treatment is recommended for a minimum 28 days.
Canine Osteomyelitis
- Oral: 5.0 mg/Ib body weight every 12 hours.
- Duration: Treatment is recommended for a minimum 28 days.
Commercial presentation:
- 1 x 6’s Tablets
